London-based company building data/mapping tools to analyze private equity expansion paths (raises funding to map what PitchBook can’t see).
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| $6.2 M | Feb, 2026 | pre-seed |
Frequently Asked Questions
Where is Thema located?
Thema is located in London, United Kingdom.
What industries does Thema operate in?
Thema operates in the following industries: data analytics, financial technology, private equity.
How much total funding has Thema raised?
Thema has raised a total of $6,200,000.
Who are the investors in Thema?
The investors in Thema are: Lead investor (unspecified), UK government (grant, in partnership with University of Cambridge), other participating investors (unspecified).
What is Thema?
Thema is an AI-powered sales intelligence platform that helps B2B organizations identify anonymous website visitors and transform them into actionable leads using intent data and automated outreach.
How does Thema identify anonymous website visitors?
Thema uses sophisticated deanonymization technology to match the digital footprints of website visitors against an extensive database of companies and professional profiles, revealing which organizations are showing interest.
What are the primary benefits of using Thema for sales teams?
Thema enables sales teams to prioritize high-intent accounts, reduce time spent on manual prospecting, and engage potential customers with highly personalized messaging based on their specific browsing behavior.
Does Thema integrate with popular CRM platforms?
Yes, Thema is designed to work seamlessly with major CRM systems like Salesforce and HubSpot, ensuring that identified leads and intent signals are automatically synced into existing sales pipelines.
How does Thema handle data privacy and compliance?
Thema prioritizes data security and adheres to global privacy regulations such as GDPR and CCPA, ensuring that all business intelligence is gathered and processed in a compliant and ethical manner.